Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the Myeloid Panel by NGS test is typically 10-14 days. This timeframe allows for sample collection, testing, analysis, and result reporting.

What are the prerequisites for the test Myeloid Panel by NGS

  • Patient must have a valid physician order for the Myeloid Panel by NGS
  • Patients must be at least 18 years of age
  • Patients must have a confirmed diagnosis of a myeloid disorder
  • Patients must not have received a bone marrow transplant within the past 6 months
  • Patients must not have received chemotherapy within the past 2 weeks

What are the measure values for the test Myeloid Panel by NGS

Test Measure Values
Myeloid Panel by NGS
  • FLT3-ITD Mutation Analysis: Positive or Negative
  • NPM1 Mutation Analysis: Positive or Negative
  • DNMT3A Mutation Analysis: Positive or Negative
  • IDH1 Mutation Analysis: Positive or Negative
  • IDH2 Mutation Analysis: Positive or Negative

What does this test Myeloid Panel by NGS identify?

  • Acute myeloid leukemia (AML) - detects mutations in genes such as FLT3, NPM1, and IDH1/2 which are commonly associated with AML
  • Chronic myeloid leukemia (CML) - identifies the BCR-ABL fusion gene which is characteristic of CML
  • Myelodysplastic syndromes (MDS) - detects mutations in genes like TP53, RUNX1, and SF3B1 which are indicative of MDS
  • Myeloproliferative neoplasms (MPN) - identifies mutations in genes such as JAK2, CALR, and MPL which are commonly found in MPN
  • Other myeloid disorders - helps in the diagnosis and classification of various other myeloid disorders based on specific genetic mutations detected

Why is this test Myeloid Panel by NGS taken?

The Myeloid Panel by NGS is taken to help diagnose and monitor various myeloid disorders, including leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. This test uses next-generation sequencing technology to analyze a panel of genes commonly associated with these disorders, providing detailed information about genetic mutations and abnormalities that may be present.

No FAQs available.

Customer Google Rating